Halper Sadeh LLC Urges CMA, ADVM, and HOUS Shareholders to Reach Out for Rights Consultation

Written by Emily J. Thompson, Senior Investment Analyst

ADVM%

HOUS+3.46%

CMA+0.1%

Source: Globenewswire

Updated: Nov 18 2025

0mins

Source: Globenewswire

Investigation of Companies: Halper Sadeh LLC is investigating Comerica Incorporated, Adverum Biotechnologies, and Anywhere Real Estate for potential violations of federal securities laws and breaches of fiduciary duties related to their proposed sales.
Comerica Sale Details: Comerica is set to be sold to Fifth Third Bancorp, with shareholders receiving 1.8663 shares of Fifth Third for each Comerica share, resulting in them owning approximately 27% of the combined company.
Adverum Sale Details: Adverum Biotechnologies will be sold to Eli Lilly, offering shareholders $3.56 per share in cash plus a contingent value right that could yield up to an additional $8.91 based on certain milestones.
Legal Support for Shareholders: Halper Sadeh LLC offers free consultations for shareholders to discuss their rights and options, emphasizing that they operate on a contingent fee basis, meaning no upfront legal fees are required.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Halper Sadeh LLC Urges CMA, ADVM, and HOUS Shareholders to Reach Out for Rights Consultation

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Trump Denies Nominating JPMorgan CEO Dimon for Fed Chair

Trump Denies Considering JPMorgan's Dimon for Fed Chair Position

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch